Analyst consensus rating
NeoGenomics Analyst Rating: Buy
Direct answer
NeoGenomics's consensus rating is Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $19.72.
Forecast evidence checked September 4, 2026.
Get free NeoGenomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $17.35
- Average price target
- $19.72
- High price target
- $35.00
- Low price target
- $16.00
- Low target gap
- -7.8%
- Target upside
- +13.7%
- High target gap
- +101.8%
- Target range width
- 109.5%
- Consensus rating
- Buy
- Analysts
- 9
- Evidence date
- September 4, 2026
- Valid through
- September 11, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for NeoGenomics?
NeoGenomics has a verified Buy consensus. The same dataset has an average price target of $19.72.
How far are NeoGenomics's low and high targets from the recorded price?
The low target implies -7.8%, while the high target implies +101.8%.
How many analysts are included in NeoGenomics's consensus?
The verified consensus includes 9 analysts.
How is NeoGenomics's target upside or downside calculated?
The average target of $19.72 is divided by the recorded price of $17.35, then one is subtracted to produce +13.7%. This does not guarantee a future return.
When was NeoGenomics's analyst forecast verified?
The data was verified on 2026-09-04. The dataset is valid through 2026-09-11.